ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 41,800 shares, an increase of 305.8% from the December 15th total of 10,300 shares. Based on an average daily trading volume, of 12,800 shares, the days-to-cover ratio is currently 3.3 days.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent SEC filing.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

Shares of ProShares UltraShort Nasdaq Biotechnology stock traded down $0.13 on Monday, hitting $18.25. The company had a trading volume of 1,958 shares, compared to its average volume of 5,321. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $14.05 and a 1 year high of $21.10. The stock has a 50 day moving average of $16.82 and a 200-day moving average of $15.80.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were issued a $0.2064 dividend. The ex-dividend date of this dividend was Monday, December 23rd. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.